Gemsenjäger E, Martina B, Heitz P U
Helv Chir Acta. 1989 Dec;56(4):481-5.
During a 15-year period (1973-1988) a consecutive series of papillary (n = 52) and follicular (n = 48) thyroid carcinomas was prospectively selected, on the basis of a clinico-pathologic and prognostic classification, for 1. non-total thyroidectomy, mostly hemithyroidectomy (n = 37), 2. total thyroidectomy (n = 19), or 3. total thyroidectomy and radioiodine (n = 44), together with exogenous suppressive thyroxine therapy in most patients. Patients with an occult or with an intrathyroidal, single papillary carcinoma without nodes, and microangioinvasive follicular carcinoma were often treated by non-total thyroidectomy or without radioiodine. During the follow-up period of 1-15 (7 +/- 4) years 5 recurrences (nodes n = 4, pulmonary n = 2) and 3 deaths occurred. Seven out of the 8 patients (age 58-76 years) had total thyroidectomy and radioiodine as initial treatment of an intrathyroidal papillary (n = 1), an extrathyroidal papillary (n = 3), and of an angioinvasive follicular (n = 4) carcinoma, respectively (no radioiodine in 1 patient). The study confirms that the outcome may be favourable in selected patients following hemithyroidectomy or without radioiodine treatment. Recurrences or death occurred in some biologically unfavourable tumors despite total thyroidectomy and radioiodine; the relatively frequent total thyroidectomy (73% of the patients) and radioiodine (51%) may have contributed to the disease-free course in the remaining patients.
在15年期间(1973 - 1988年),根据临床病理和预后分类,前瞻性地选取了一系列连续的乳头状甲状腺癌(n = 52)和滤泡状甲状腺癌(n = 48)患者,进行如下治疗:1. 非全甲状腺切除术,主要是甲状腺半叶切除术(n = 37);2. 全甲状腺切除术(n = 19);3. 全甲状腺切除术加放射性碘治疗(n = 44),大多数患者同时接受外源性甲状腺素抑制治疗。隐匿性或甲状腺内单发性乳头状癌且无淋巴结转移以及微小血管侵犯性滤泡状癌的患者,常采用非全甲状腺切除术或不进行放射性碘治疗。在1至15年(7±4年)的随访期内,发生了5例复发(4例为淋巴结复发,2例为肺转移)和3例死亡。8例患者(年龄58 - 76岁)中,7例分别对甲状腺内乳头状癌(n = 1)、甲状腺外乳头状癌(n = 3)和血管侵犯性滤泡状癌(n = 4)进行了全甲状腺切除术加放射性碘作为初始治疗(1例患者未进行放射性碘治疗)。该研究证实,对于部分患者,甲状腺半叶切除术或不进行放射性碘治疗可能有良好的预后。尽管进行了全甲状腺切除术和放射性碘治疗,一些生物学行为不良的肿瘤仍会出现复发或死亡;相对较高比例的全甲状腺切除术(73%的患者)和放射性碘治疗(51%)可能有助于其余患者实现无病病程。